Improved quality control of [177Lu]Lu-PSMA I&T

Improved quality control of [177Lu]Lu-PSMA I&T

Abstract Background Targeted radionuclide therapy with [177Lu]Lu-PSMA I&T (zadavotide guraxetan) has proven high efficacy and safety in treating patients with advanced prostate cancer worldwide. Several methods to determine the radiochemical purity have been reported but also limitations in the...

Full description

Bibliographic Details
Main Authors: Martin Kraihammer, Piotr Garnuszek, Andreas Bauman, Michael Maurin, Manuel Alejandre Lafont, Roland Haubner, Elisabeth von Guggenberg, Michael Gabriel, Clemens Decristoforo
Format: Article
Language:English
Published: SpringerOpen 2023-03-01
Series:EJNMMI Radiopharmacy and Chemistry
Subjects:
PSMA
[177Lu]Lu-PSMA I&T
Zadavotide guraxetan
Radionuclide therapy
Quality control
HPLC
Online Access:https://doi.org/10.1186/s41181-023-00191-6

Internet

https://doi.org/10.1186/s41181-023-00191-6

Similar Items